Virology News and Research

Latest Virology News and Research

Gene therapy holds promise in treating cancer, cardiovascular and neurodegenerative diseases

Gene therapy holds promise in treating cancer, cardiovascular and neurodegenerative diseases

Zetiq completes clinical trial of CellDetect technology for early identification of cervical cancer

Zetiq completes clinical trial of CellDetect technology for early identification of cervical cancer

ABL to host CRP-Santé COMET subtyping tool within TherapyEdge servers

ABL to host CRP-Santé COMET subtyping tool within TherapyEdge servers

Telefonica Mexico, Myriad Group nominated for 'Service: Social Use' at 2010 Global Messaging Awards

Telefonica Mexico, Myriad Group nominated for 'Service: Social Use' at 2010 Global Messaging Awards

Understanding HIV viral protein structure could lead to new molecular medicines: Study

Understanding HIV viral protein structure could lead to new molecular medicines: Study

AIDS specialist leaves Calif. practice, citing rising costs

AIDS specialist leaves Calif. practice, citing rising costs

Neurologix announces positive results from Phase 2 trial of NLX-P101 for advanced PD

Neurologix announces positive results from Phase 2 trial of NLX-P101 for advanced PD

SynCon DNA vaccine shows advantages in magnitude and breadth of immune responses in non-human primates

SynCon DNA vaccine shows advantages in magnitude and breadth of immune responses in non-human primates

BD, PEPFAR commence multi-year initiative to improve blood collection practices in African clinics, hospitals

BD, PEPFAR commence multi-year initiative to improve blood collection practices in African clinics, hospitals

Health leaders formally launch new strategy for polio eradication

Health leaders formally launch new strategy for polio eradication

FDA approves ARCHITECT HIV Ag/Ab Combo assay to aid in diagnosis of HIV-1/HIV-2 infection

FDA approves ARCHITECT HIV Ag/Ab Combo assay to aid in diagnosis of HIV-1/HIV-2 infection

FDA approves Abbott's ARCHITECT HIV Ag/Ab Combo assay

FDA approves Abbott's ARCHITECT HIV Ag/Ab Combo assay

NanoViricides' anti-Dengue drug candidates demonstrate potential against severe virus infection

NanoViricides' anti-Dengue drug candidates demonstrate potential against severe virus infection

CFIDS Association applauds AABB for responding to questions about safety of general blood supply

CFIDS Association applauds AABB for responding to questions about safety of general blood supply

Oncolytics Biotech issued patent that covers methods for treating cell proliferative disorders

Oncolytics Biotech issued patent that covers methods for treating cell proliferative disorders

Preclinical study shows treatment with DAS181 inhibits infection with multiple HPIV strains

Preclinical study shows treatment with DAS181 inhibits infection with multiple HPIV strains

Children's Hospital Boston receives $2.4M Gates Foundation grant to develop novel neonatal vaccines

Children's Hospital Boston receives $2.4M Gates Foundation grant to develop novel neonatal vaccines

90% of HCV patients to be treated with triple therapy regimens, finds Decision Resources

90% of HCV patients to be treated with triple therapy regimens, finds Decision Resources

New multimillion dollar BSL-3 laboratory complex at Nigerian National TB and Leprosy Training Center

New multimillion dollar BSL-3 laboratory complex at Nigerian National TB and Leprosy Training Center

Mount Sinai School of Medicine, Alnylam collaborate to develop microRNA-based attenuated influenza viruses

Mount Sinai School of Medicine, Alnylam collaborate to develop microRNA-based attenuated influenza viruses

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.